ClinicalTrials.gg
Not yet recruitingNCT07898358Updated Oct 27, 2026

Music Therapy and Sedation for Pain and Anxiety During Oocyte Retrieval

An observational study in ANXIETY, sponsored by Samsun University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Samsun University · Observational

Updated Oct 27, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
146
Sex
Female
01

Study summary

This study is a prospective observational investigation aimed at examining the effect of music intervention on anxiety and pain levels in patients undergoing the ovum pick-up (OPU) procedure under sedation at an IVF center.

The ovum pick-up procedure is a process that is both psychologically stressful and performed under sedation. High levels of anxiety and pain experienced before and during the procedure can reduce patient comfort and increase the need for sedative or analgesic medications. The aim of this study is to evaluate whether listening to music during sedation reduces patients' anxiety levels and to assess its impact on pain perception.

The results obtained may demonstrate the potential of music, as a non-pharmacological method, to enhance patient comfort during procedures performed under sedation.

The study includes female patients scheduled for the OPU procedure under sedation at an IVF center. Participants will listen to music via headphones during the procedure without undergoing any additional pharmacological or interventional measures. Participation will be voluntary, and written informed consent will be obtained.

02

Conditions studied

  • ANXIETY

Browse trials for

03

In context

Anxiety Disorders

5,073 studies on the registry are indexed under Anxiety Disorders; 1,406 are open to participants now.

This study's planned enrollment of 146 is close to the median of 148 across 630 observational studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Samsun University is the lead sponsor of 87 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Female patients undergoing the IVF procedure

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Female patients aged 18-45,

  • Scheduled for an OPU procedure,
  • Candidates for sedation (ASA I-II).

Exclusion criteria

Exclusion Criteria:

  • Individuals with hearing impairment,
  • Individuals with psychiatric disorders or chronic analgesic use,
  • Individuals with contraindications to the sedation protocol.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
146 participants (estimated)
Patient registry
No

Groups and cohorts

  • MUSIC

    Patients whose anxiety levels were measured while listening to music

  • CONTROL

    Patients whose anxiety was measured without exposure to music

06

What researchers measure

Primary outcomes

  1. ANXIETY

    Anxiety levels in these patients will be assessed using the State-Trait Anxiety Inventory (STAI). This widely established 40-item psychological instrument measures anxiety across two distinct dimensions. Total scores range between 20 and 80, where higher scores reflect greater anxiety severity.

    Time frame: 1 YEAR

  2. Measuring Anxiety Through Music Listening

    Anxiety levels in these patients will be assessed using the State-Trait Anxiety Inventory (STAI). This widely established 40-item psychological instrument measures anxiety across two distinct dimensions. Total scores range between 20 and 80, where higher scores reflect greater anxiety severity.

    Time frame: 1 YEAR

07

Study locations

1 site
  • Samsun Universitesi
    Samsun, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — WILL NOT BE SHARED IN ORDER TO PROTECT PATIENTS' PERSONAL DATA

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Jun 2027, 8 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 28, 2026
First posted
Oct 27, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Dec 31, 2027
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07898358
Lead sponsor
Samsun University
Responsible party
Sponsor
First posted
Oct 27, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 27, 2026

Study contacts

Hatice Bahadır Altun, SPECIALIST
Contact
haticebahadirmd@hotmail.com
+905075775727
GOKCE ULTAN OZGEN, SPECIALIST
Contact
gokceozgen55@gmail.com
+905067750245
Hatice Bahadır Altun, SPECIALIST
principal investigator · SAMSUN UNIVERSITESI

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion